Pacific Biosciences Of California (PACB) Current Leases (2019 - 2026)

Pacific Biosciences Of California's Current Leases history runs 8 years deep, the most recent figure standing at $277000.0 for Q1 2026.

• In Q1 2026, Current Leases fell 88.54% year-over-year to $277000.0; the TTM figure through Mar 2026 stood at $277000.0 (down 88.54% YoY), while the FY2025 annual figure was $448000.0, down 95.53% from the prior year.
• Current Leases was $277000.0 for Q1 2026 at Pacific Biosciences Of California, down from $448000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $12.5 million in Q2 2024 to a low of $277000.0 in Q1 2026.
• Historically, Current Leases has averaged $7.0 million across 5 years, with a median of $8.9 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Current Leases jumped 81.12% in 2022, then sank 95.53% in 2025.
• A 5-year view of Current Leases shows it stood at $8.9 million in 2022, then advanced by 7.93% to $9.6 million in 2023, then increased by 4.54% to $10.0 million in 2024, then tumbled by 95.53% to $448000.0 in 2025, then slumped by 38.17% to $277000.0 in 2026.
• The last three Current Leases figures came in at $277000.0 (Q1 2026), $448000.0 (Q4 2025), and $621000.0 (Q3 2025), per Business Quant data.